drugset / Trial / NCT06270199
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
Phase 2
Recruiting
75 enrolled
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
RandomizedParallel-groupOpen-labelTreatment
Summary
Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.
Timeline
- Start
- 2024-01-11
- Primary completion
- 2025-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogenic fetal mesenchymal stem cells from umbilical cord | Cell therapy | 5e+06 cells/kg | — |